Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma
Clinical trial NCT07699939 · RECRUITING
Trial details
- NCT number
- NCT07699939
- Sponsor
- National Cancer Center, Japan
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-15
- Primary completion
- 2028-11-30
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.